Correlation Between Telkom Indonesia and Crescita Therapeutics

Can any of the company-specific risk be diversified away by investing in both Telkom Indonesia and Crescita Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telkom Indonesia and Crescita Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Telkom Indonesia Tbk and Crescita Therapeutics, you can compare the effects of market volatilities on Telkom Indonesia and Crescita Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telkom Indonesia with a short position of Crescita Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telkom Indonesia and Crescita Therapeutics.

Diversification Opportunities for Telkom Indonesia and Crescita Therapeutics

-0.73

Correlation Coefficient

Telkom Indonesia  Crescita Therapeutics

Pay attention - limited upside

The 3 months correlation between Telkom and Crescita is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Telkom Indonesia Tbk and Crescita Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crescita Therapeutics and Telkom Indonesia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telkom Indonesia Tbk are associated (or correlated) with Crescita Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crescita Therapeutics has no effect on the direction of Telkom Indonesia i.e., Telkom Indonesia and Crescita Therapeutics go up and down completely randomly.

Pair Corralation between Telkom Indonesia and Crescita Therapeutics

Considering the 90-day investment horizon Telkom Indonesia Tbk is expected to under-perform the Crescita Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Telkom Indonesia Tbk is 73.51 times less risky than Crescita Therapeutics. The stock trades about -0.12 of its potential returns per unit of risk. The Crescita Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  2.10  in Crescita Therapeutics on September 3, 2024 and sell it today you would earn a total of  42.90  from holding Crescita Therapeutics or generate 2042.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.46%
Values	Daily Returns

Telkom Indonesia Tbk  vs.  Crescita Therapeutics

Telkom Indonesia Tbk

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Telkom Indonesia Tbk has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Crescita Therapeutics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Crescita Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Crescita Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Telkom Indonesia and Crescita Therapeutics

The main advantage of trading using opposite Telkom Indonesia and Crescita Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telkom Indonesia position performs unexpectedly, Crescita Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescita Therapeutics will offset losses from the drop in Crescita Therapeutics' long position.

The idea behind Telkom Indonesia Tbk and Crescita Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.